Press release
Co-Chairs from Aerie Pharmaceuticals & Santen Inc USA Invite Industry Experts to join Ophthalmic Drugs
The conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing great clinical trial data. There will also be a specific focus on drug delivery along with advancements in novel technologies. Further key areas will be gene therapy and Artificial Intelligence with developments on the latest drug pipelines and clinical trials.
The conference is co-chaired by Mitchell A. (Mitch) de Long who holds the position of vice president, Chemistry at Aerie Pharmaceuticals as well as Adjunct Professor of Chemistry at Duke University. Since Mitch helped to found Aerie as a Duke University spinout in 2005, Aerie has filed 5 INDs and 2 NDAs, with its first FDA approval coming in 2017 and
Najam (Naj) Sharif, PhD, DSc (Southampton University, UK) has >34-years' pharmaceutical drug discovery research/development experience covering neuroscience and ophthalmology. He is Currently the Vice President of Global Alliances and External Research, Ophthalmology Innovation Center at Santen Inc USA.
The co-chairs Mitchell de Long and Naj Sharif invitation letter to join the conference mentions:
"The Ophthalmic Drugs conference will bring together expertise from individuals in multiple disciplines of the field. Our packed agenda will offer a series of presentations, through which you will gain insight into new industry developments and clinical trials, innovations in the treatment of rare diseases, regulatory perspectives, and advances in gene therapy"
"As the Co-chairs of this conference, we look forward to personally welcoming you to this must-attend conference in London this November."
The full invitation chair letter can be found in the brochure at www.ophthalmicdrugs.com/pr4openpr
Key benefits of attending, incude
• Assess new industry directions through the latest data from ophthalmic clinical trials
• Review advanced techniques in treating age-related diseases of ophthalmology
• Explore evolving therapeutic potential in undruggable diseases through innovative gene therapies
• Examine novel methodologies in delivery technologies being used to further the ophthalmic therapeutic field
• Engage in the regulatory landscape of ophthalmic drugs and key considerations for R&D
The Ophthalmic Drugs Conference is proudly sponsored by Celanese, Ora, Inc., TTP Plc.
For sponsorship enquiries contact Andrew Gibbons, Project Manager in +44 (0) 20 7827 6156 or andrew.gibbons@saemediagroup.com
For media partnerships and press enquiries contact Simi Sapal, Head of Marketing on +44 (0)827 or email simi.sapal@saemediagroup.com
Ophthalmic Drugs
21-22 November 2022
London, UK
www.ophthalmicdrugs.com/pr4openpr
#OphthalmicDrugs
Ophthalmic Drugs
21-22 November 2022
London, UK
www.ophthalmicdrugs.com/pr4openpr
#OphthalmicDrugs
About SAE Media Group Conferences:
SAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace, Pharmaceutical and Medical. Each year we bring together over 5,000 senior business professionals at our conferences. http://www.smgconferences.com
SAE Media Group (SMG), a subsidiary of SAE International, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1,000,000 engineers, researchers, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Co-Chairs from Aerie Pharmaceuticals & Santen Inc USA Invite Industry Experts to join Ophthalmic Drugs here
News-ID: 2779949 • Views: …
More Releases from SAE Media Group
Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture
SAE Media Group reports: Conference co-chairs invite delegates to join the anticipated 6th Annual 3D Cell Culture Conference
SAE Media Group is delighted to announce the return of successful 3D Cell Culture Conference for its 6th year, taking place on 8 and 9 February 2023 in London, UK.
The 2023 Conference theme is on exploring the implementation of complex in-vitro models for drug development
Visit the website at http://www.3d-cellculture.com/PR2 to find out…
Exploring the Implementation of Complex In-vitro Models for Drug Development
SAE Media Group reports: Agenda and speaker overview released for the 6th Annual 3D Cell Culture Conference, London, UK
SAE Media Group is delighted to announce the return of successful 3D Cell Culture Conference for its 6th year, taking place on 8 and 9 February 2023 in London, UK.
3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to…
We listened your feedback for Transdermal and Microneedle Drug Delivery Conferen …
SAE Media Group's Transdermal and Microneedle Drug Delivery conference returns to London for the 2nd year on 23 - 24 January 2023 and will focus on exploring the advances in microneedle diagnostics through case studies and real-world examples, whilst engaging in modern strategies for topical and transdermal drug delivery.
Vaccine delivery will be a significant aspect of this year's agenda with a focus on microneedle delivery technologies as a mode for…
Senior Officers and Military leaders and Experts from around the globe will spea …
SAE Media Group are delighted to announce the return of the 8th Annual Maritime Reconnaissance and Surveillance Technology Conference, taking place in London on the 1st and 2nd of February 2023 at the Copthorne Tara Hotel. All the information you need for the event is now available!
We remain as the only Maritime ISR conference focusing solely on Space-Based Domain Awareness. In this year's upcoming event, you will be able…
More Releases for Ophthalmic
Ophthalmic Trial Frames Market Depth Survey Report 2019| Topcon, Luneau, Takagi …
Ophthalmic trial frames are adjustable frames that are used to hold lenses during refraction test and during retinoscopy test of the eye. Ophthalmic trial frames are eyeglasses designed in such a way that different lenses can be inserted and can be used to correct refractive errors of vision. Ophthalmic trial frames are light weight, adjustable and should have a comfortable nose resting and can be adjusted to allow accurate centering.…
Ophthalmic Eye Shield Market Segmentation By Material type Aluminium Ophthalmic …
Eye shields are advised for use in the eye while a periorbital surgery to avoid any injury to the globe. Ophthalmic eye shields are used for postoperative ocular protection. Ophthalmic eye shields protect the cornea and retina while any eye surgery or laser treatment. Ophthalmic eye shields are highly preferred for cataract surgeries in the elder population and blepharitis correction especially for children. According to WHO, The World Health Organization,…
Eye socket Implants Market Offered in New Research Forecasted through 2026 // Ke …
The global Eye socket Implants market is expected to see remarkable growth in the forecast period due to increase in work-related eye injuries. Increase in the number of patients drives the overall eye socket implants market. Higher adoption of surgeries in higher economic regions propels the Eye socket Implants Market. Others factors like increasing prevalence and incidence of eye-related disease, changing lifestyle pattern are the factors which are fueling the…
Ophthalmic Surgical Technologies Market - Femtosecond Systems Likely to Dominate …
The global ophthalmic surgical technologies market is driven mainly by the growing funding in the healthcare sector and the rising awareness about eye care, added to the rising prevalence of eye diseases. The ophthalmic surgical technologies market has enjoyed a supportive regulatory and economic structure in most regions in the recent past and is thus likely to continue on the strong growth trajectory it has exhibited in recent years. Increasing…
Ophthalmic Lasers Market: Demand for Ophthalmic Lasers to Remain Higher in North …
Lasers have become an essential part of treatment modality for a number of practicing ophthalmologist. Ophthalmic lasers have gained prominence with the popularity of laser-assisted surgeries for rectifying nearsightedness or myopia. The increasing incidence of ophthalmic disorders and rise in geriatric population in various regions have boosted the application of different types of lasers in treating specific eye problems and improving vision. Technological advances have significantly increased the safety and…
Ophthalmic Ultrasound Device Market: A-scan Ophthalmic Ultrasound Devices High i …
Global Ophthalmic Ultrasound Device Market: Snapshot
The constantly increasing percentage of the geriatric population across the world is widely considered as the primary factor augmenting the demand for ophthalmic ultrasound devices. The high geriatric population is directly linked to the increasing patient count for ocular diseases and disorders, along with chronic diseases such as diabetes. The increasing levels of pollution are also responsible for the high volume of ovular disorders across…
